Vigabatrin Tablet, Film Coated
Product Images NDC 70771-1654
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 70771-1654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Dda2d40b 9f09 4d9f 9073 6f6be5024838 02)
Image (Dda2d40b 9f09 4d9f 9073 6f6be5024838 03)
Image (Dda2d40b 9f09 4d9f 9073 6f6be5024838 04)
Each film coated tablet of Vigabatrin contains 500mg Vigabatrin USP. The tablets must be dispensed in a tight, light-resistant container as defined in the USP. The drug should be stored at a temperature of 20° to 25°C (68° to 77°F). This package is child-resistant, hence must be kept out of reach of children. For more information, refer to the Medication Guide available at www.zydususa.com/medguides or call 1-877-993-8779. This product is manufactured by Cadila Healthcare Ltd_India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.